FIELD: chemistry.
SUBSTANCE: invention relates to novel substituted pyridinyl carbamates of general formula (I) , where R1 and R2 are independently selected from hydrogen, hydroxy, sulfanyl, amino, amide, urea, thiourea, benzamide, thioamide, halogen, sulfo, C1-6-alkyl, C1-6-alkoxy, C2-6-alkenyl, aryl, heteroaryl, C3-8-heterocyclyl and C3-10-cycloalkyl, wherein each of hydroxy, sulfanyl, amino, amide, urea, thiourea, benzamide, thioamide, sulfo, C1-6-alkyl, C1-6-alkoxy, C2-6-alkenyl, aryl, heteroaryl, C3-8-heterocyclyl and C3-10-cycloalkyl can be substituted with one or more substituents independently selected from hydroxy, sulfanyl, oxo, thioxo, halogen, amino, sulfo, C1-6-alkyl, C1-6-alkoxy, C2-6-alkenyl, aryl, heteroaryl, C3-8-heterocyclyl, and C3-10-cycloalkyl, wherein each of hydroxy, sulfanyl, sulfo, C1-6-alkyl, C1-6-alkoxy, C2-6-alkenyl, aryl, heteroaryl, C3-8-heterocyclyl and C3-10-cycloalkyl can be substituted with one or more substituents independently selected from hydroxy, sulfanyl, oxo, halogen, amino, sulfo, perhalomethyl, perhalomethoxy, C1-6-alkyl, C1-6-alkoxy, C2-6-alkenyl, aryl, heteroaryl, C3-8-heterocyclyl, and C3-10-cycloalkyl ; R3, and R4 are independently selected from hydrogen, hydroxy, sulfanyl, halogen, amino, sulfo, C1-6-alkyl, C2-6-alkenyl, aryl, heteroaryl, C3-8-heterocyclyl and C3-10-cycloalkyl, wherein each of hydroxy, sulfanyl, amino, sulfo, C1-6-alkyl, C2-6-alkenyl, aryl, heteroaryl, C3-8-heterocyclyl and C3-10-cycloalkyl can be substituted with one or more substituents independently selected from hydroxy, sulfanyl, oxo, halogen, amino, sulfo, C1-6-alkyl, C2-6-alkenyl, aryl, heteroaryl, C3-8-heterocyclyl and C3-10-cycloalkyl, wherein each of hydroxy, sulfanyl, amino, sulfo, C1-6-alkyl, C2-6-alkenyl, aryl, heteroaryl, C3-8-heterocyclyl and C3-10-cycloalkyl can be substituted with one or more substituents independently selected from hydroxy, sulfanyl, oxo, halogen, amino, C1-6-alkyl, perhalomethyl and perhalomethoxy. Invention also relates to pharmaceutical composition, possessing activity of inhibiting lipolytic activity of hormone-sensitive lipase, which contains compounds of formula (I), to their application for treatment and/or prevention of diseases and disorders, related to hormone-sensitive lipase and to method of their production.
EFFECT: obtaining novel compounds, possessing useful biological properties.
23 cl, 1 tbl, 77 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS AND THEIR USING FOR DECREASING HORMONE-SENSITIVE LIPASE ACTIVITY | 2002 |
|
RU2317981C2 |
PYRROLIDINE DERIVATIVES | 2010 |
|
RU2562605C2 |
APOPTOSIS-INDUCING AGENTS | 2018 |
|
RU2782469C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS NADPH-OXIDASE INHIBITORS | 2009 |
|
RU2538041C2 |
PYRROLOPYRAZINE KINASE INHIBITORS | 2009 |
|
RU2503676C2 |
CROSS-COMBINATION METHODS | 2017 |
|
RU2777977C2 |
SUBSTITUTED PHENOXYACETIC ACIDS, THEIR ESTERS AND AMIDES CONTAINING 2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PYRIN-8-YL FRAGMENTS - A ADENOSINE RECEPTOR ANTAGONISTS AND USE THEREOF | 2011 |
|
RU2477726C1 |
PYRAZOLE PYRIDINE DERIVATIVES AS NADPH-OXIDASE | 2009 |
|
RU2548022C2 |
SUBSTITUTED NICOTINAMIDES AS KCNQ2-3 MODULATORS | 2010 |
|
RU2529904C2 |
ARYLETHINYL DERIVATIVES | 2011 |
|
RU2573560C2 |
Authors
Dates
2008-11-10—Published
2004-06-08—Filed